BIOVAIL LABORATORIES INTERNATIONAL SRL logo

BIOVAIL LABORATORIES INTERNATIONAL SRL

20 Marks
First Filed:Oct 23, 2001Latest Filed:May 16, 2007Address:Welches, Christ Church, BB17154, BB

Portfolio Overview

Dead
20(100%)
Previous
22

Top Classes

Class 5
Pharmaceuticals
18(90%)
Class 1
Industrial Chemicals & Adhesives
1(5%)
Class 9
Electronics, Software & Scientific Equipment
1(5%)

TTAB Proceedings

Total Proceedings
6
As Plaintiff
1(17%)
As Defendant
5(83%)

Top Firms

Pirkey Barber PLLC(Mar 2011)
23
BAUSCH HEALTH COMPANIES(Mar 2011)
7
Bausch + Lomb Law Department(Mar 2011)
6
Holley & Menker, PA(Jul 2009)
3
Smith, Gambrell & Russell, L...(Dec 2003)
2

Trademark Activity Timeline(2001 – 2007)

Trademark Portfolio

42 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
CARDISENSE
CARDISENSE
Trademark
Word
ABANDONED
Owner:
Serial:77182237
Filed:May 16, 2007
Classes:9
Goods & Services
Downloadable electronic publications in the nature of newsletters, pamphlets and bulletins in the field of health issues; electronic publications, namely, newsletters, pamphlets and bulletins in the field of health issues recorded on computer media
INSTATAB
INSTATAB
Trademark
Word
ABANDONED
Owner:
Serial:78931095
Filed:Jul 17, 2006
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan; rapidly dissolving drug delivery agents consisting of compounds that facilitate the delivery of a wide variety of pharmaceuticals
JOVOLA
JOVOLA
Trademark
Word
ABANDONED
Owner:
Serial:78862891
Filed:Apr 17, 2006
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
JUBLIA
JUBLIA
Trademark
Word
ABANDONED
Owner:
Serial:78862951
Filed:Apr 17, 2006
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
PALVATA
PALVATA
Trademark
Word
ABANDONED
Owner:
Serial:78862931
Filed:Apr 17, 2006
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
SOLBRI
SOLBRI
Trademark
Word
ABANDONED
Owner:
Serial:78862981
Filed:Apr 17, 2006
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
MIVURA
MIVURA
Trademark
Word
ABANDONED
Owner:
Serial:78851363
Filed:Mar 31, 2006
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
TESIVEE
TESIVEE
Trademark
Word
ABANDONED
Owner:
Serial:78851273
Filed:Mar 31, 2006
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
VEMRETA
VEMRETA
Trademark
Word
ABANDONED
Owner:
Serial:78851392
Filed:Mar 31, 2006
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
VOLZELO
VOLZELO
Trademark
Word
ABANDONED
Owner:
Serial:78851320
Filed:Mar 31, 2006
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
FLASHDOSE
FLASHDOSE
Trademark
Word
ABANDONED
Owner:
Serial:78543928
Filed:Jan 7, 2005
Classes:5
ZILERAN
ZILERAN
Trademark
Word
ABANDONED
Owner:
Serial:78518422
Filed:Nov 17, 2004
Classes:5
APLENZIN
APLENZIN
Trademark
Word
ABANDONED
Owner:
Serial:78340327
Filed:Dec 12, 2003
Classes:5
GLUZERA
GLUZERA
Trademark
Word
ABANDONED
Owner:
Serial:78340245
Filed:Dec 12, 2003
Classes:5
ONEXTEN
ONEXTEN
Trademark
Word
ABANDONED
Owner:
Serial:78340386
Filed:Dec 12, 2003
Classes:5
TOVALT
TOVALT
Trademark
Word
ABANDONED
Owner:
Serial:76504006
Filed:Apr 4, 2003
Classes:5
Goods & Services
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CNS AND CNS RELATED DISORDERS AND CONDITIONS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF PAIN; PAIN RELIEF MEDICATIONS; ANALGESICS AND TRAMADOL
UPZIMIA
UPZIMIA
Trademark
Word
ABANDONED
Owner:
Serial:76504005
Filed:Apr 4, 2003
Classes:5
Goods & Services
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CNS AND CNS RELATED DISORDERS AND CONDITIONS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF PAIN; PAIN RELIEF MEDICATIONS; ANALGESICS AND TRAMADOL
UPZIVA
UPZIVA
Trademark
Word
ABANDONED
Owner:
Serial:76504007
Filed:Apr 4, 2003
Classes:5
Goods & Services
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CNS AND CNS RELATED DISORDERS AND CONDITIONS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF PAIN; PAIN RELIEF MEDICATIONS; ANALGESICS AND TRAMADOL
ORAMELT
ORAMELT
Trademark
Word
ABANDONED
Owner:
Serial:76439672
Filed:Aug 8, 2002
Classes:5
Goods & Services
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM, THE IMMUNE SYSTEM, THE CARDIO-VASCULAR SYSTEM, THE RESPIRATORY SYSTEM, THE MUSCULO-SKELETAL SYSTEM, FOR THE TREATMENT OF INFLAMMATORY DISORDERS, AND FOR USE IN DERMATOLOGY ONCOLOGY, AND OPHTHALMOLOGY
INSTATAB
INSTATAB
Trademark
Word
ABANDONED
Owner:
Serial:76328659
Filed:Oct 23, 2001
Classes:1
Goods & Services
RAPIDLY DISSOLVING PREPARATIONS FOR USE IN THE MANUFACTURE OF HUMAN AND VETERINARY MEDICINAL PRODUCTS
JOVOLA
JOVOLA
Trademark
Word
Previous
CANCELLED
Owner:
Serial:85261936
Filed:Mar 9, 2011
Classes:5
Registration:4651130
Registered:Dec 9, 2014
Goods & Services
Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Parkinson's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Huntington's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of amyotropic lateral sclerosis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Alzheimer's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Tourette Syndrome; pharmaceutical preparations and substances for the prevention, treatment and alleviation of epilepsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of multiple sclerosis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of cardio-pulmonary disorders, diseases, conditions, and ailments; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions, and ailments of the circulatory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension, high blood pressure, heart filure and ventricular dysfunction; pharmaceutical preparations and substances for the prevention, treatment and alleviation of metabolic disorders, diseases, conditions and ailments; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of viral and infectious diseases; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, cerebral palsy, insomnia, mood disorders, bipolar disorder, seizure disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations for the treatment of immunologic diseases, namely, auto immune motility diseases, immunologic deficiency syndromes, auto immune diseases, Acquired Immune Deficiency Syndrome (AIDS), hypersensitivity, allergies, tumors of the immunological organs; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculoskeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
JUBLIA
JUBLIA
Trademark
Word
Previous
REGISTERED
Owner:
Serial:85261969
Filed:Mar 9, 2011
Classes:5
Registration:4359772
Registered:Jul 2, 2013
Goods & Services
Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations [ ; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system ]
MIVURA
MIVURA
Trademark
Word
Previous
ABANDONED
Owner:
Serial:85262084
Filed:Mar 9, 2011
Classes:5
Goods & Services
Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system
PALVATA
PALVATA
Trademark
Word
Previous
CANCELLED
Owner:
Serial:85262092
Filed:Mar 9, 2011
Classes:5
Registration:4647300
Registered:Dec 2, 2014
Goods & Services
Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations and substances for use in chemotherapy; Pharmaceutical preparations and substances for use in urology; pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, anti-inflammatories and pain relief medication; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances for the treatment of fungal infections, onychomycosis, tinea infections, and similar diseases of the skin and nails; pharmaceutical preparations and substances for use in dermatological conditions
ZILERAN
ZILERAN
Trademark
Word
Previous
ABANDONED
Owner:
Serial:77905797
Filed:Jan 6, 2010
Classes:5
Goods & Services
Pharmaceutical preparations for the treatment of disorders, diseases, conditions and ailments, namely, eye drops, ophthalmic preparations, and pharmaceutical preparations for the treatment of eye diseases and the treatment of ocular disorders; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the central nervous system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Parkinson's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Huntington's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of amyotrophic lateral sclerosis; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Alzheimer's disease; Pharmaceutical preparations and substances for the prevention, treatment and alleviation of Tourette Syndrome; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of epilepsy; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of multiple sclerosis; pharmaceutical preparations and substances for the treatment of depression, depressive disorders and mental illnesses; antidepressants; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of anxiety; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of pain; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the cardiovascular system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of cardiopulmonary disorders, diseases, conditions, and ailments; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the circulatory system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of hypertension, angina, high blood pressure, heart failure and ventricular dysfunction; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of metabolic disorders, diseases, conditions, and ailments; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of diabetes; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of viral and infectious diseases
FLASHDOSE
FLASHDOSE
Trademark
Word
Previous
ABANDONED
Owner:
Serial:77789291
Filed:Jul 24, 2009
Classes:5
ONEXTEN
ONEXTEN
Trademark
Word
Previous
CANCELLED
Owner:
Serial:77599980
Filed:Oct 24, 2008
Classes:5
Registration:4231795
Registered:Oct 30, 2012
Goods & Services
PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF DISEASES, ILLNESSES, DISORDERS, AILMENTS OR CONDITIONS OF THE CENTRAL NERVOUS SYSTEM; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF DEPRESSION, DEPRESSIVE DISORDERS AND MENTAL ILLNESSES; ANTIDEPRESSANTS; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION, TREATMENT, AND ALLEVIATION OF PARKINSON'S DISEASE; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION, TREATMENT, AND ALLEVIATION OF HUNTINGTON'S DISEASE; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION, TREATMENT, AND ALLEVIATION OF AMYOTROPHIC LATERAL SCLEROSIS; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION, TREATMENT, AND ALLEVIATION OF ALZHEIMER'S DISEASE; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION, TREATMENT, AND ALLEVIATION OF EPILEPSY; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION, TREATMENT, AND ALLEVIATION OF MULTIPLE SCLEROSIS; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF ANXIETY; AND PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION, TREATMENT, AND ALLEVIATION OF PAIN
APLENZIN
APLENZIN
Trademark
Word
Previous
REGISTERED
Owner:
Serial:77594316
Filed:Oct 16, 2008
Classes:5
Registration:3650117
Registered:Jul 7, 2009
Goods & Services
PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF DISEASES, ILLNESSES, DISORDERS, AILMENTS OR CONDITIONS OF THE CENTRAL NERVOUS SYSTEM; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF DEPRESSION, DEPRESSIVE DISORDERS AND MENTAL ILLNESSES; ANTIDEPRESSANTS
ORAMELT
ORAMELT
Trademark
Word
Previous
CANCELLED
Owner:
Serial:77543711
Filed:Aug 11, 2008
Classes:5
Registration:4247772
Registered:Nov 27, 2012
Goods & Services
Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the central nervous system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Parkinson's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Huntington's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of amyotrophic lateral sclerosis; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Alzheimer's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of epilepsy; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of multiple sclerosis; pharmaceutical preparations and substances for the treatment of depression, depressive disorders and mental illnesses; antidepressants; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of anxiety; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of pain; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the cardiovascular system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of cardiopulmonary disorders, diseases, conditions, and ailments; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the circulatory system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of hypertension, angina, high blood pressure, heart failure and ventricular dysfunction; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of metabolic disorders, diseases, conditions, and ailments; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of diabetes; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of viral and infectious diseases; Drug delivery agents consisting of rapidly dissolving compounds, formulations, compositions and agents that facilitate delivery of a wide range of human and veterinary pharmaceuticals; and Drug delivery agents in the nature of pill coatings that facilitate delivery of a wide range of human and veterinary pharmaceuticals; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Tourette syndrome
TITRADOSE
TITRADOSE
Trademark
Word
Previous
REGISTERED
Owner:
Serial:77396172
Filed:Feb 13, 2008
Classes:5
Registration:3597399
Registered:Mar 31, 2009
Goods & Services
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF ANGINA; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION, TREATMENT AND ALLEVIATION OF CIRCULATORY DISEASES, ILLNESSES, DISORDERS OR CONDITIONS; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION, TREATMENT AND ALLEVIATION OF DISORDERS, DISEASES, CONDITIONS AND AILMENTS OF THE CARDIO-VASCULAR SYSTEM; DRUG DELIVERY SYSTEM IN THE NATURE OF IMMEDIATE RELEASE COMPOUNDS, POLYMERS, AGENTS OR FORMULATIONS SOLD AS AN INTEGRAL COMPONENT OF PHARMACEUTICAL PREPARATIONS
SHEARFORM
SHEARFORM
Trademark
Word
Previous
ABANDONED
Owner:
Serial:77390719
Filed:Feb 6, 2008
Classes:5
Goods & Services
Pharmaceutical and drug delivery ingredients sold as an integral component of pharmaceutical preparations; rapidly-dissolving formulations, compositions and agents consisting of coatings, additives and compounds that facilitate the delivery of a wide variety of pharmaceuticals; drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents sold as an integral component of pharmaceutical preparations; drug delivery system comprising polymer-based oral tablets for the controlled release of a wide variety of therapeutic agents sold as an integral component of pharmaceutical preparations
UPZIMIA
UPZIMIA
Trademark
Word
Previous
ABANDONED
Owner:
Serial:77383919
Filed:Jan 30, 2008
Classes:5
Goods & Services
PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION, TREATMENT AND ALLEVIATION OF DISORDERS, DISEASES, CONDITIONS AND AILMENTS OF THE CENTRAL NERVOUS SYSTEM; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF PAIN; PAIN RELIEF MEDICATIONS; ANALGESICS
TOVALT
TOVALT
Trademark
Word
Previous
CANCELLED
Owner:
Serial:77254549
Filed:Aug 14, 2007
Classes:5
Registration:4228254
Registered:Oct 23, 2012
Goods & Services
pharmaceutical preparations and substances for the prevention and treatment of disorders, diseases, conditions and ailments of the immune system, cardio-vascular system, the respiratory system, and the musculo-skeletal system; pharmaceutical preparations and substances acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of inflammatory disorders; pharmaceutical preparations and substances for the prevention and treatment of hypertension; pharmaceutical preparations and substances for the prevention and treatment of oncological and metabolical disorders, diseases, conditions and ailments; pharmaceutical products for ophthalmological use; and pharmaceutical preparations and substances for use in dermatology; pharmaceutical preparations and substances for the treatment of depression and obsessive compulsive disorders
CARDISENSE
CARDISENSE
Trademark
Word
Previous
CANCELLED
Owner:
Serial:77983218
Filed:May 16, 2007
Classes:16, 41, 44
Registration:4277644
Registered:Jan 22, 2013
Goods & Services
Providing on-line publications in the nature of newsletters, pamphlets and bulletins in the field of health issues; Publications in the nature of newsletters, pamphlets and bulletins in the field of health issues; Providing a website featuring information and advice in the field of health issues
ASOLZA
ASOLZA
Trademark
Word
Previous
CANCELLED
Owner:
Serial:78851378
Filed:Mar 31, 2006
Classes:5
Registration:4116673
Registered:Mar 27, 2012
Goods & Services
Pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain, namely, pain relief medication; excluding pain relief medication delivered by transdermal plasters or transdermal patches; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; metformin; diltiazem; and tramadol
ONELZA
ONELZA
Trademark
Word
Previous
ABANDONED
Owner:
Serial:78851346
Filed:Mar 31, 2006
Classes:5
Goods & Services
Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking excluding pharmaceutical preparations and substances delivered by transdermal plasters or transdermal patches; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, anti-inflammatories and pain relief medication excluding pain relief medication delivered by transdermal plasters or transdermal patches; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
SMARTCOAT
SMARTCOAT
Trademark
Word
Previous
CANCELLED
Owner:
Serial:78297563
Filed:Sep 8, 2003
Classes:5
Registration:3716931
Registered:Nov 24, 2009
TIAZAC
TIAZAC
Trademark
Word
Previous
REGISTERED
Owner:
Serial:74454789
Filed:Nov 5, 1993
Classes:5
Registration:1988853
Registered:Jul 23, 1996
Goods & Services
pharmaceutical for the treatment of angina and hypertension
VASERETIC
VASERETIC
Trademark
Word
Previous
REGISTERED
Owner:
Serial:73503117
Filed:Oct 9, 1984
Classes:5
Registration:1335085
Registered:May 14, 1985
Goods & Services
Medicinal Preparation for Use in the Treatment of Cardiovascular Diseases
VASOTEC
VASOTEC
Trademark
Word
Previous
REGISTERED
Owner:
Serial:73465852
Filed:Feb 15, 1984
Classes:5
Registration:1348858
Registered:Jul 16, 1985
Goods & Services
Pharmaceutical Preparation for Use in the Treatment of Cardiovascular Diseases
STINGOSE
STINGOSE
Trademark
Word
Previous
CANCELLED
Owner:
Serial:73259973
Filed:Apr 28, 1980
Classes:5
Registration:1256575
Registered:Nov 8, 1983
Goods & Services
Lotions for Application to Skin for the Relief of Stingings and Other Invenomations
ISORDIL
ISORDIL
Trademark
Word
Previous
REGISTERED
Owner:
Serial:72081865
Filed:Sep 23, 1959
Classes:5, 18
Registration:0697014
Registered:May 3, 1960
Goods & Services
CARDIOVASCULAR AGENT

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.